CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,764,000
- in 1 filing, $1.8M under 10b5-1 plans
Net −$1,764,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-09 | Grossman Jerrold B Director | Sale | −10,000 | $21.31 | $213K | 478,194 |
| 2025-06-09 | Grossman Jerrold B Director | Option exercise · Stock Option (right to buy) | −10,000 | 0 | ||
| 2025-05-22 | Guiheen Lawrence P. Director | Option exercise | +1,221 | $5.96 | $7K | 116,051 |
| 2025-05-22 | Guiheen Lawrence P. Director | Sale | −1,221 | $20.12 | $25K | 114,830 |
| 2025-05-22 | Guiheen Lawrence P. Director | Option exercise · Stock Option (right to buy) | −1,221 | 0 | ||
| 2025-05-21 | Guiheen Lawrence P. Director | Option exercise | +7,779 | $5.96 | $46K | 122,609 |
| 2025-05-21 | Guiheen Lawrence P. Director | Sale | −7,779 | $20.32 | $158K | 114,830 |
| 2025-05-21 | Guiheen Lawrence P. Director | Option exercise · Stock Option (right to buy) | −7,779 | 1,221 | ||
| 2025-05-15 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,070,850 |
| 2025-05-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $19.45 | $292K | 2,055,850 |
| 2025-05-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $19.45 | $117K | 2,049,850 |
| 2025-05-15 | Grossman Adam S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 825,950 | ||
| 2025-04-15 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,076,850 |
| 2025-04-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $21.46 | $322K | 2,061,850 |
| 2025-04-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $21.46 | $129K | 2,055,850 |
| 2025-04-15 | Grossman Adam S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 840,950 | ||
| 2025-04-01 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for taxes | −18,920 | $19.42 | $367K | 490,425 |
| 2025-03-19 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,082,850 |
| 2025-03-19 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $18.92 | $284K | 2,067,850 |
| 2025-03-19 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $18.92 | $114K | 2,061,850 |
Page 7 of 31 · 618 trades